ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1050

Diagnostic Accuracy of Lung Ultrasound for Detecting Interstitial Lung Disease Among Patients with Systemic Sclerosis: A Comparative Study of Two Scanning Protocols

Fabian Carranza Enriquez1, Carina Soto-Fajardo1, Sinthia Solorzano Flores1, Abish Angeles-Acuña1, Mayra Mejia-Avila2, Amyrari Vázquez-Ortega3, Paola Flores-Ordoñez2, Karina Arias Callejas2, Alejandra Enriquez-Luna4, Graciliano Ramon-Diaz4, Brenda Bravo-Zarate2, Tatiana Sofía Rodríguez-Reyna3 and Carlos Pineda4, 1Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico, 2Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico, 3Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 4Instituto Nacional de Rehabilitacion, Mexico City, Mexico

Meeting: ACR Convergence 2023

Keywords: Computed tomography (CT), Imaging, interstitial lung disease, Systemic sclerosis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1033–1051) Imaging of Rheumatic Diseases Poster I

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Lung ultrasound (LUS) has proven useful to detect interstitial lung disease (ILD) among patients with SSc when compared to high-resolution computerized tomography (HRCT) as the gold standard; it also exhibits advantages as a tool in clinical practice owing to its accessibility and innocuity. Nevertheless, a key drawback is currently the lack of a standardized methodology to perform LUS. Our objectives were to evaluate diagnostic accuracy of LUS for ILD by comparing the systematic evaluation of 14 intercostal spaces (ICS) against 12 postero-basal ICS; and to correlate the grade of severity of ILD assessed through LUS with findings on HRCT, both as a global score and evaluating specific concordant lung zones.

Methods: Patients with SSc, according to current classification criteria, were recruited from the outpatient rheumatology clinic at a referral hospital. Demographic, clinical, serological, and imaging variables were collected. LUS was performed using two scanning methods: 14 predetermined ICS and 12 postero-basal ICS. “B” lines (BL) and pleural abnormalities (PA) were documented for each ICS. HRCT was performed with a maximum 3 month-interval from the time of recruitment (before or after). Descriptive statistics, multivariate analysis, a Pearson correlation test (to compare findings between LUS and HRCT), and ROC curves (to show diagnostic accuracy) were carried out.

Results: We included 114 patients with a median age of 55 (IQR 48-63) years; 97.4% were women. Prevalence of ILD was 49.1%. Relevant baseline characteristics are shown in Table 1. Acknowledged risk factors for ILD were pulmonary hypertension (OR 3.4, CI 95% 1.04-11.14, p=0.04) and diffuse SSc (OR 2.5, CI 95% 0.84-7.6 p= 0.10). A strong correlation was shown between the BL count in 14 ICS and the Warrick score (0.62), and the BL count in 12 ICS and Warrick score (0.61).

The AUC were 0.85 (95% CI, 0.77-0.92), 0.88 (95% CI, 0.82-0.95) and 0.83 (95% CI, 0.75-0.91) for the evaluation of the number of BL in 14 ICS, 12 ICS and the number of ICS with PA (22 EIC), respectively.

Conclusion: Our study confirms the robustness of LUS as a tool for the detection of ILD through the quantification of BL and PA when using any of two different scanning protocols (14 and 12 ICS). A reasonable diagnostic accuracy was also proven for the finding of PA, but more studies are required to elucidate their added value over BL for the diagnosis of ILD by LUS.

Supporting image 1

Supporting image 2


Disclosures: F. Carranza Enriquez: None; C. Soto-Fajardo: None; S. Solorzano Flores: None; A. Angeles-Acuña: None; M. Mejia-Avila: None; A. Vázquez-Ortega: None; P. Flores-Ordoñez: None; K. Arias Callejas: None; A. Enriquez-Luna: None; G. Ramon-Diaz: None; B. Bravo-Zarate: None; T. Rodríguez-Reyna: None; C. Pineda: None.

To cite this abstract in AMA style:

Carranza Enriquez F, Soto-Fajardo C, Solorzano Flores S, Angeles-Acuña A, Mejia-Avila M, Vázquez-Ortega A, Flores-Ordoñez P, Arias Callejas K, Enriquez-Luna A, Ramon-Diaz G, Bravo-Zarate B, Rodríguez-Reyna T, Pineda C. Diagnostic Accuracy of Lung Ultrasound for Detecting Interstitial Lung Disease Among Patients with Systemic Sclerosis: A Comparative Study of Two Scanning Protocols [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/diagnostic-accuracy-of-lung-ultrasound-for-detecting-interstitial-lung-disease-among-patients-with-systemic-sclerosis-a-comparative-study-of-two-scanning-protocols/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnostic-accuracy-of-lung-ultrasound-for-detecting-interstitial-lung-disease-among-patients-with-systemic-sclerosis-a-comparative-study-of-two-scanning-protocols/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology